Literature DB >> 21631393

Paradoxical action of growth factors: antiproliferative and proapoptotic signaling by HGF/c-MET.

Barbara Grzelakowska-Sztabert1, Magdalena Dudkowska.   

Abstract

Hepatocyte growth factor (HGF)/mesenchymal-epithelial transition factor (c-MET) signaling is usually associated with the promotion of cellular growth and often with progression of tumors. Nevertheless, under certain conditions HGF can also act as an antiproliferative and proapoptotic factor and can sensitize various cancer cells, treated with anticancer drugs, to apoptosis. Not only HGF but also its various truncated forms as well as intracellular fragments of its membrane receptor, c-MET, may act as antiproliferative and proapoptotic factors toward various cells. This review focuses on different mechanisms responsible for such paradoxical action of the known typical growth factor. It also points toward the possibilities of usage of this information in anticancer therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21631393     DOI: 10.3109/08977194.2011.585609

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  3 in total

1.  Celastrol exerts synergistic effects with PHA-665752 and inhibits tumor growth of c-Met-deficient hepatocellular carcinoma in vivo.

Authors:  Hong-Lei Jiang; Jun-Zhe Jin; Dan Wu; Dong Xu; Guo-Fu Lin; Hao Yu; Dong-Yan Ma; Jian Liang
Journal:  Mol Biol Rep       Date:  2013-05-07       Impact factor: 2.316

2.  HGF Secreted by Activated Kupffer Cells Induces Apoptosis of Plasmodium-Infected Hepatocytes.

Authors:  Lígia Antunes Gonçalves; Joana Rodo; Lurdes Rodrigues-Duarte; Luciana Vieira de Moraes; Carlos Penha-Gonçalves
Journal:  Front Immunol       Date:  2017-02-06       Impact factor: 7.561

3.  Dental pulp-derived stem cell conditioned medium reduces cardiac injury following ischemia-reperfusion.

Authors:  Satoshi Yamaguchi; Rei Shibata; Noriyuki Yamamoto; Masaya Nishikawa; Hideharu Hibi; Tohru Tanigawa; Minoru Ueda; Toyoaki Murohara; Akihito Yamamoto
Journal:  Sci Rep       Date:  2015-11-06       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.